Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Phase III data support long-term efficacy of TAF against HBV
18 Jul 2023
bởiAudrey Abella
Two phase III studies presented at EASL 2023 reflected the long-term efficacy of tenofovir alafenamide (TAF) for individuals with HBeAg*-positive and HBeAg-negative chronic hepatitis B virus (HBV).
Phase III data support long-term efficacy of TAF against HBV
18 Jul 2023
‘Triple-G’ obesity drug also targets NAFLD in phase II trial
11 Jul 2023
bởiAudrey Abella
In a subanalysis of a phase II trial on obesity, retatrutide, a triagonist of GIP*, GLP**, and glucagon receptors, also demonstrated multiple favourable signals for nonalcoholic fatty liver disease (NAFLD).
‘Triple-G’ obesity drug also targets NAFLD in phase II trial
11 Jul 2023
Gas-filled on par with fluid-filled IGB for obesity treatment
28 Jun 2023
Current Food and Drug Administration (FDA)-approved intragastric balloon (IGB) systems, the gas-filled IGB (Obalon) and the fluid-filled IGB (Orbera), demonstrate similar effectiveness for the treatment of obesity, as shown in a recent study.
